title: [Sjögren's syndrome: therapeutic trends].
abstract: Sjögren syndrome is an autoimmune, mostly benign disorder characterized by functional impairment of exocrine glands, especially of the salivary and lacrimal glands. Symptomatic treatment with recourse to hygienic measures and topical therapy permits to attenuate secondary disorders due to hyposecretion. Among drugs used, hydrochloroquine has proved apt to bring about marked improvement in some laboratory test results although it has scarce effect on the clinical picture. Corticosteroids and immunodepressant agents are indicated in severe forms of the disease with accompanying extraglandular and systemic manifestations. Some authors have reported interesting findings concerning the usefulness of a low lipid diet which is said to reduce inflammation and lymphocyte infiltration of the glands involved; these findings deserve further research.
authors.affiliation: Cattedra di Reumatologia, Università degli Studi di Ancona.
authors.forename: G
authors.initials: G
authors.lastname: Di Giacinto
authors.forename: G
authors.initials: G
authors.lastname: Piergiacomi
mesh_terms: D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D012859:Sjogren's Syndrome / Q000178:diet therapy / Q000188:drug therapy / Q000628:therapy*
chemical_list: D000305:Adrenal Cortex Hormones; D007166:Immunosuppressive Agents
vernacular_title: La sindrome di Sjoegren: attualità terapeutiche.